Matches in Nanopublications for { ?s ?p "[In breast tumors, overexpression was the main alteration observed for PKC?/? (33.4%), PKC? (29.5%) and PKC? (9.6%), whereas underexpression was the main alteration observed for PKC? (27.3%), PKC? (11.6%), PKC? (8.7%) and PKN2 (8.1%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP872476.RAcwp-lVnvKH3ilYp9DXhIgx3qIzscvPwCDHzrOHWXWPU130_assertion description "[In breast tumors, overexpression was the main alteration observed for PKC?/? (33.4%), PKC? (29.5%) and PKC? (9.6%), whereas underexpression was the main alteration observed for PKC? (27.3%), PKC? (11.6%), PKC? (8.7%) and PKN2 (8.1%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP872476.RAcwp-lVnvKH3ilYp9DXhIgx3qIzscvPwCDHzrOHWXWPU130_provenance.
- NP926176.RA9l7V3a3Ayl6oAF_D5P2BIKBdZXDzLMiFOjmTE78DSx4130_assertion description "[In breast tumors, overexpression was the main alteration observed for PKC?/? (33.4%), PKC? (29.5%) and PKC? (9.6%), whereas underexpression was the main alteration observed for PKC? (27.3%), PKC? (11.6%), PKC? (8.7%) and PKN2 (8.1%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926176.RA9l7V3a3Ayl6oAF_D5P2BIKBdZXDzLMiFOjmTE78DSx4130_provenance.
- NP875283.RA8kJ7BEFgQ8JtIIL7n6FSlQGbfws3Ov_cPxOrVBaAlhI130_assertion description "[In breast tumors, overexpression was the main alteration observed for PKC?/? (33.4%), PKC? (29.5%) and PKC? (9.6%), whereas underexpression was the main alteration observed for PKC? (27.3%), PKC? (11.6%), PKC? (8.7%) and PKN2 (8.1%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP875283.RA8kJ7BEFgQ8JtIIL7n6FSlQGbfws3Ov_cPxOrVBaAlhI130_provenance.
- assertion description "[In breast tumors, overexpression was the main alteration observed for PKC?/? (33.4%), PKC? (29.5%) and PKC? (9.6%), whereas underexpression was the main alteration observed for PKC? (27.3%), PKC? (11.6%), PKC? (8.7%) and PKN2 (8.1%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In breast tumors, overexpression was the main alteration observed for PKC?/? (33.4%), PKC? (29.5%) and PKC? (9.6%), whereas underexpression was the main alteration observed for PKC? (27.3%), PKC? (11.6%), PKC? (8.7%) and PKN2 (8.1%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In breast tumors, overexpression was the main alteration observed for PKC?/? (33.4%), PKC? (29.5%) and PKC? (9.6%), whereas underexpression was the main alteration observed for PKC? (27.3%), PKC? (11.6%), PKC? (8.7%) and PKN2 (8.1%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP975619.RAZtbtMOZ1SVNPMNpS2LjLh_Yx9GYqmFWvTTmKi2NTYLg130_assertion description "[In breast tumors, overexpression was the main alteration observed for PKC?/? (33.4%), PKC? (29.5%) and PKC? (9.6%), whereas underexpression was the main alteration observed for PKC? (27.3%), PKC? (11.6%), PKC? (8.7%) and PKN2 (8.1%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP975619.RAZtbtMOZ1SVNPMNpS2LjLh_Yx9GYqmFWvTTmKi2NTYLg130_provenance.
- NP642605.RAkv4VyCmZ2FgVaSnkQt1k_7rDZwTpfokJImQZagfaYUw130_assertion description "[In breast tumors, overexpression was the main alteration observed for PKC?/? (33.4%), PKC? (29.5%) and PKC? (9.6%), whereas underexpression was the main alteration observed for PKC? (27.3%), PKC? (11.6%), PKC? (8.7%) and PKN2 (8.1%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642605.RAkv4VyCmZ2FgVaSnkQt1k_7rDZwTpfokJImQZagfaYUw130_provenance.
- NP643609.RAuSZJly7xCDBhI-Ae2CY_yNYsLhZRpWOoMDtGxvBGBB8130_assertion description "[In breast tumors, overexpression was the main alteration observed for PKC?/? (33.4%), PKC? (29.5%) and PKC? (9.6%), whereas underexpression was the main alteration observed for PKC? (27.3%), PKC? (11.6%), PKC? (8.7%) and PKN2 (8.1%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643609.RAuSZJly7xCDBhI-Ae2CY_yNYsLhZRpWOoMDtGxvBGBB8130_provenance.
- NP975617.RAq-WictsDs-pagM7dDfOa4ktsqKOFuIAttk4AH8PTAf8130_assertion description "[In breast tumors, overexpression was the main alteration observed for PKC?/? (33.4%), PKC? (29.5%) and PKC? (9.6%), whereas underexpression was the main alteration observed for PKC? (27.3%), PKC? (11.6%), PKC? (8.7%) and PKN2 (8.1%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP975617.RAq-WictsDs-pagM7dDfOa4ktsqKOFuIAttk4AH8PTAf8130_provenance.
- NP643169.RA62irnNjrv4P6rogXYHYhhrF9TUH8PCrJzVirMJzjy80130_assertion description "[In breast tumors, overexpression was the main alteration observed for PKC?/? (33.4%), PKC? (29.5%) and PKC? (9.6%), whereas underexpression was the main alteration observed for PKC? (27.3%), PKC? (11.6%), PKC? (8.7%) and PKN2 (8.1%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643169.RA62irnNjrv4P6rogXYHYhhrF9TUH8PCrJzVirMJzjy80130_provenance.
- NP975616.RAxraP3r3I9Orq3kbagkYYyZa_g-z7UC655TukkCFS8Iw130_assertion description "[In breast tumors, overexpression was the main alteration observed for PKC?/? (33.4%), PKC? (29.5%) and PKC? (9.6%), whereas underexpression was the main alteration observed for PKC? (27.3%), PKC? (11.6%), PKC? (8.7%) and PKN2 (8.1%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP975616.RAxraP3r3I9Orq3kbagkYYyZa_g-z7UC655TukkCFS8Iw130_provenance.